Surya Singh, MD

Internal Medicine

Internal Medicine

Doctorpedia Profile

Dr. Singh is actively licensed board certified in internal medicine. He is currently the CEO of gWell, Inc, a genomics and wellness focused digital health company, and serves as a senior advisor and board member for mission aligned companies and non-profits. In addition, he is an Adjunct Instructor of Medicine at Harvard Medical School. He was formerly Corporate Vice-President and Chief Medical Officer of Specialty Pharmacy at CVS Health, and was an attending physician for many years at the Brigham and Women’s Hospital in Boston.

Education

  • MD: Johns Hopkins University School of Medicine

  • BS: University of Texas at Austin

Board Certifications

  • American Board of Internal Medicine

  • LATEST ACTIVITY
  • VIDEOS
  • ARTICLES
  • APP REVIEWS
  • BLOG
  • PODCASTS

Videos

Genomics – Optimizing Treatment

I think genomics, along with epigenomics or how genes are expressed and turned on or off, as well as proteomics, how the entire spectrum of proteins that are produced by cells interact with each other...

Watch and Share

Videos

Genetics – Innovation

“In 10 years, I expect that gene and cellular therapies will have proliferated, hopefully much more than we can currently conceive. I think there’ll be dozens of different gene therapies and even more than one...

Watch and Share

Videos

Gene Therapy – Morality

“For several decades, even centuries, people have thought through the ramifications of being able to modify genetic material, in essence, to be able to have “”designer babies.”” Gene therapy is nothing of this sort. Gene...

Watch and Share

Videos

Gene Therapy – Durability

So the durability or how long gene therapies will last is one of the biggest questions facing this new class of treatment. Unfortunately, the answer is complicated. We don’t yet know how long even the...

Watch and Share

Videos

Cancer – CAR-T Therapy

“So CAR-T cell treatments are one of the newest approaches to cancer treatment. It’s a part of a field and a movement called immunooncology. Essentially we’re using immune system cells from the patient themselves and...

Watch and Share

Videos

Cancer – Genetics

“So we all know that there are families where cancer is much more prevalent. Basically we say that cancer runs in those families, and we know that there’s a hereditary component that’s passed from one...

Watch and Share

Videos

Gene Therapy – Costs

“The second big area is the ethical question and dilemma of how to get these treatments, these life-saving treatments, to patients across the globe. But the cost of the most recently launched gene therapy in...

Watch and Share

Videos

Tumor Genomics – Treatment Plan

I think that tumor genomics will be routinely used in structuring the treatment plan for patients early in the process. Basically, at the time that a particular tumor is detected, the tumor specimen will be...

Watch and Share

Videos

Genetics – Future Development

First, in 10 years, I see the proliferation of tools that allow for these technologies to be used in much more practical ways, by both patients and clinicians will have vastly improved. They should be...

Watch and Share

Videos

Gene Therapy – Safety

Gene therapy is under rigorous evaluation by researchers, developers, regulators, and other officials all converging to try to understand all the different aspects of safety when you inject DNA material into cells. This was the...

Watch and Share
welcome

Nothing yet..

This doctor has not yet uploaded content to this section

welcome

Nothing yet..

This doctor has not yet uploaded content to this section

welcome

Nothing yet..

This doctor has not yet uploaded content to this section

welcome

Nothing yet..

This doctor has not yet uploaded content to this section

welcome

Nothing yet..

This doctor has not yet uploaded content to this section

Send this to a friend